PURPOSE: Positron emission tomography (PET) with 11C-labelled Pittsburgh compound B ([11C]PIB) enables the quantitation of beta-amyloid accumulation in the brain of patients with Alzheimer's disease (AD). Voxel-based image analysis techniques conducted in a standard brain space provide an objective, rapid and fully automated method to analyze [11C]PIB PET data. The purpose of this study was to evaluate both region- and voxel-level reproducibility of automated and simplified [11C]PIB quantitation when using only 30 min of imaging data. METHODS: Six AD patients and four healthy controls were scanned twice with an average interval of 6 weeks. To evaluate the feasibility of short scanning (convenient for AD patients), [11C]PIB uptake was quantitated using 30 min of imaging data (60 to 90 min after tracer injection) for region-to-cerebellum ratio calculations. To evaluate the reproducibility, a test-retest design was used to derive absolute variability (VAR) estimates and intraclass correlation coefficients at both region-of-interest (ROI) and voxel level. RESULTS: The reproducibility both at the region level (VAR 0.9-5.5%) and at the voxel level (VAR 4.2-6.4%) was good to excellent. Based on the variability estimates obtained, power calculations indicated that 90% power to obtain statistically significant difference can be achieved using a sample size of five subjects per group when a 15% change from baseline (increase or decrease) in [11C]PIB accumulation in the frontal cortex is anticipated in one group compared to no change in another group. CONCLUSION: Our results showed that an automated analysis method based on an efficient scanning protocol provides reproducible results for [11C]PIB uptake and appears suitable for PET studies aiming at the quantitation of amyloid accumulation in the brain of AD patients for the evaluation of progression and treatment effects.
PURPOSE: Positron emission tomography (PET) with 11C-labelled Pittsburgh compound B ([11C]PIB) enables the quantitation of beta-amyloid accumulation in the brain of patients with Alzheimer's disease (AD). Voxel-based image analysis techniques conducted in a standard brain space provide an objective, rapid and fully automated method to analyze [11C]PIB PET data. The purpose of this study was to evaluate both region- and voxel-level reproducibility of automated and simplified [11C]PIB quantitation when using only 30 min of imaging data. METHODS: Six ADpatients and four healthy controls were scanned twice with an average interval of 6 weeks. To evaluate the feasibility of short scanning (convenient for ADpatients), [11C]PIB uptake was quantitated using 30 min of imaging data (60 to 90 min after tracer injection) for region-to-cerebellum ratio calculations. To evaluate the reproducibility, a test-retest design was used to derive absolute variability (VAR) estimates and intraclass correlation coefficients at both region-of-interest (ROI) and voxel level. RESULTS: The reproducibility both at the region level (VAR 0.9-5.5%) and at the voxel level (VAR 4.2-6.4%) was good to excellent. Based on the variability estimates obtained, power calculations indicated that 90% power to obtain statistically significant difference can be achieved using a sample size of five subjects per group when a 15% change from baseline (increase or decrease) in [11C]PIB accumulation in the frontal cortex is anticipated in one group compared to no change in another group. CONCLUSION: Our results showed that an automated analysis method based on an efficient scanning protocol provides reproducible results for [11C]PIB uptake and appears suitable for PET studies aiming at the quantitation of amyloid accumulation in the brain of ADpatients for the evaluation of progression and treatment effects.
Authors: Brian J Lopresti; William E Klunk; Chester A Mathis; Jessica A Hoge; Scott K Ziolko; Xueling Lu; Carolyn C Meltzer; Kurt Schimmel; Nicholas D Tsopelas; Steven T DeKosky; Julie C Price Journal: J Nucl Med Date: 2005-12 Impact factor: 10.057
Authors: Henry Engler; Anton Forsberg; Ove Almkvist; Gunnar Blomquist; Emma Larsson; Irina Savitcheva; Anders Wall; Anna Ringheim; Bengt Långström; Agneta Nordberg Journal: Brain Date: 2006-07-19 Impact factor: 13.501
Authors: Scott K Ziolko; Lisa A Weissfeld; William E Klunk; Chester A Mathis; Jessica A Hoge; Brian J Lopresti; Steven T DeKosky; Julie C Price Journal: Neuroimage Date: 2006-08-14 Impact factor: 6.556
Authors: N M Kemppainen; S Aalto; I A Wilson; K Någren; S Helin; A Brück; V Oikonen; M Kailajärvi; M Scheinin; M Viitanen; R Parkkola; J O Rinne Journal: Neurology Date: 2007-05-08 Impact factor: 9.910
Authors: Elina Salmi; Sargo Aalto; Jussi Hirvonen; Jaakko W Långsjö; Anu T Maksimow; Vesa Oikonen; Liisa Metsähonkala; Jussi Virkkala; Kjell Någren; Harry Scheinin Journal: Neuroimage Date: 2008-03-04 Impact factor: 6.556
Authors: Arthur Mikhno; Davangere Devanand; Gregory Pelton; Katrina Cuasay; Roger Gunn; Neil Upton; Robert Y Lai; Vincenzo Libri; J John Mann; Ramin V Parsey Journal: J Nucl Med Date: 2008-07-16 Impact factor: 10.057
Authors: C C Rowe; S Ng; U Ackermann; S J Gong; K Pike; G Savage; T F Cowie; K L Dickinson; P Maruff; D Darby; C Smith; M Woodward; J Merory; H Tochon-Danguy; G O'Keefe; W E Klunk; C A Mathis; J C Price; C L Masters; V L Villemagne Journal: Neurology Date: 2007-05-15 Impact factor: 9.910
Authors: Gunnar Blomquist; Henry Engler; Agneta Nordberg; Anna Ringheim; Anders Wall; Anton Forsberg; Sergio Estrada; Pernilla Frändberg; Gunnar Antoni; Bengt Långström Journal: Open Neuroimag J Date: 2008-11-13
Authors: Fabio Raman; Sameera Grandhi; Charles F Murchison; Richard E Kennedy; Susan Landau; Erik D Roberson; Jonathan McConathy Journal: J Alzheimers Dis Date: 2019 Impact factor: 4.472
Authors: Timo Grimmer; Susanne Tholen; Behrooz H Yousefi; Panagiotis Alexopoulos; Annette Förschler; Hans Förstl; Gjermund Henriksen; William E Klunk; Chester A Mathis; Robert Perneczky; Christian Sorg; Alexander Kurz; Alexander Drzezga Journal: Biol Psychiatry Date: 2010-07-02 Impact factor: 13.382
Authors: Timo Suotunen; Jussi Hirvonen; Pirjo Immonen-Räihä; Sargo Aalto; Irina Lisinen; Eveliina Arponen; Mika Teräs; Kari Koski; Raimo Sulkava; Marko Seppänen; Juha O Rinne Journal: Eur J Nucl Med Mol Imaging Date: 2010-02-09 Impact factor: 9.236
Authors: N M Kemppainen; N M Scheinin; J Koivunen; J Johansson; J T Toivonen; K Någren; J Rokka; M Karrasch; R Parkkola; J O Rinne Journal: Eur J Nucl Med Mol Imaging Date: 2013-09-27 Impact factor: 9.236
Authors: Sargo Aalto; Kimmo Ingman; Kati Alakurtti; Valtteri Kaasinen; Jussi Virkkala; Kjell Någren; Juha O Rinne; Harry Scheinin Journal: J Cereb Blood Flow Metab Date: 2014-12-10 Impact factor: 6.200
Authors: Agneta Nordberg; Stephen F Carter; Juha Rinne; Alexander Drzezga; David J Brooks; Rik Vandenberghe; Daniela Perani; Anton Forsberg; Bengt Långström; Noora Scheinin; Mira Karrasch; Kjell Någren; Timo Grimmer; Isabelle Miederer; Paul Edison; Aren Okello; Koen Van Laere; Natalie Nelissen; Mathieu Vandenbulcke; Valentina Garibotto; Ove Almkvist; Elke Kalbe; Rainer Hinz; Karl Herholz Journal: Eur J Nucl Med Mol Imaging Date: 2012-09-08 Impact factor: 9.236
Authors: Luping Zhou; Olivier Salvado; Vincent Dore; Pierrick Bourgeat; Parnesh Raniga; S Lance Macaulay; David Ames; Colin L Masters; Kathryn A Ellis; Victor L Villemagne; Christopher C Rowe; Jurgen Fripp Journal: PLoS One Date: 2014-01-10 Impact factor: 3.240